Empresa Arcturus Therapeutics Holdings Inc.
Acciones
ARCT
US03969T1097
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
26,55 USD | +1,45 % | +2,19 % | -15,79 % |
Resumen de negocios
Número de empleados: 180
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Nucleic Acid-focused Technology
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 206 | 100,0 % | 167 | 100,0 % | -19,03 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/03/13 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/09/19 |
Chief Operating Officer | 45 | 01/01/13 | |
Chief Tech/Sci/R&D Officer | 68 | 01/03/23 | |
Neda Safarzadeh
IRC | Investor Relations Contact | - | - |
Lance Kurata
LAW | General Counsel | 54 | 10/08/20 |
Kevin T. Skol
PRN | Corporate Officer/Principal | - | 01/01/02 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Edward W. Holmes
BRD | Director/Board Member | 83 | 01/09/19 |
James F. Barlow
BRD | Director/Board Member | 65 | 27/05/18 |
Peter Farrell
CHM | Chairman | 81 | 27/05/18 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/09/19 |
Magda Marquet
BRD | Director/Board Member | 65 | 27/05/18 |
Jing Marantz
BRD | Director/Board Member | 59 | 07/12/21 |
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/03/13 |
John Markels
BRD | Director/Board Member | 58 | 08/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 915 243 | 24 560 665 ( 91,25 %) | 0 | 91,25 % |
Información de la empresa
Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive Suite 250
92121, San Diego
+
http://www.arcturusrx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,79 % | 715 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción ARCT
- Empresa Arcturus Therapeutics Holdings Inc.